These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17760559)

  • 1. Big tumor regression induced by GM-CSF gene-modified 3LL tumor cells via facilitating DC maturation and deviation toward CD11c+CD8alpha+ subset.
    Lin Y; Xiong S; Zhang L; Zhang Y; Cai Y; Xu L; Chu Y
    DNA Cell Biol; 2007 Dec; 26(12):863-72. PubMed ID: 17760559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
    Chu Y; Wang LX; Yang G; Ross HJ; Urba WJ; Prell R; Jooss K; Xiong S; Hu HM
    J Immunother; 2006; 29(4):367-80. PubMed ID: 16799332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.
    Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D; Carbone DP
    Hum Gene Ther; 1997 Jan; 8(2):187-93. PubMed ID: 9017422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function.
    Miller G; Pillarisetty VG; Shah AB; Lahrs S; Xing Z; DeMatteo RP
    J Immunol; 2002 Sep; 169(6):2875-85. PubMed ID: 12218100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells.
    Guo J; Zhang M; Wang B; Yuan Z; Guo Z; Chen T; Yu Y; Qin Z; Cao X
    Int J Cancer; 2003 Jan; 103(2):212-20. PubMed ID: 12455035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
    Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
    Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
    Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
    BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W; He L; Cao X
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice.
    Morita T; Ikeda K; Douzono M; Yamada M; Kimura F; Kawakami K; Sasaki K; Motoyoshi K; Takahara J; Irino S
    Blood; 1996 Aug; 88(3):955-61. PubMed ID: 8704254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
    Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K
    Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
    He SB; Sun K; Wang L; Li DC; Zhang YY
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
    Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
    J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
    Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.
    Park KH; Kim G; Jang SH; Kim CH; Kwon SY; Yoo CG; Kim YW; Kwon HC; Kim CM; Han SK; Shim YS; Lee CT
    Anticancer Res; 2003; 23(2B):1559-64. PubMed ID: 12828142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.
    Liu B; Tan W; Barsoum A; Gu X; Chen K; Huang W; Ramsay A; Kolls JK; Schwarzenberger P
    Exp Hematol; 2010 Oct; 38(10):877-884.e1. PubMed ID: 20600582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
    Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.